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Essential tremor is the most common movement disorder and has an unknown etiology. Here we report that 
γ-aminobutyric acidA (GABAA) receptor α1–/– mice exhibit postural and kinetic tremor and motor incoordina-
tion that is characteristic of essential tremor disease. We tested mice with essential-like tremor using current 
drug therapies that alleviate symptoms in essential tremor patients (primidone, propranolol, and gabapentin) 
and several candidates hypothesized to reduce tremor, including ethanol; the noncompetitive N-methyl-D-
aspartate receptor antagonist MK-801; the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine 
(CCPA); the GABAA receptor modulators diazepam, allopregnanolone, and Ro15-4513; and the L-type Ca2+ 
channel antagonist nitrendipine. Primidone, propranolol, and gabapentin reduced the amplitude (power) of 
the pathologic tremor. Nonsedative doses of ethanol eliminated tremor in mice. Diazepam, allopregnanolone, 
Ro15-4513, and nitrendipine had no effect or enhanced tremor, whereas MK-801 and CCPA reduced tremor. 
To understand the etiology of tremor in these mice, we studied the electrophysiological properties of cerebellar 
Purkinje cells. Cerebellar Purkinje cells in GABAA receptor α1–/– mice exhibited a profound loss of all respons-
es to synaptic or exogenous GABA, but no differences in abundance, gross morphology, or spontaneous syn-
aptic activity were observed. This genetic animal model elucidates a mechanism of GABAergic dysfunction in 
the major motor pathway and potential targets for pharmacotherapy of essential tremor.
Introduction
As the most common movement disorder, with higher prevalence 
than Parkinson disease, essential tremor can be both socially 
and physically debilitating, rendering patients unable to write, 
clothe themselves, or feed themselves (1, 2). In contrast to resting 
tremor found in Parkinson disease, essential tremor is character-
ized by postural and kinetic components (3). Postural tremor is 
an involuntary oscillation that occurs when a posture is main-
tained against gravity. Essential tremor worsens during move-
ment, adding a kinetic component to the disorder that results in 
disturbances in tandem gait and ataxia in approximately 50% of 
patients (4). First-line treatments for essential tremor include the 
anticonvulsant primidone and the β-adrenergic blocker proprano-
lol, although their mechanisms of action are unknown (5). Like 
primidone, gabapentin is an anticonvulsant serendipitously found 
to be effective in the treatment of essential tremor (6, 7). The old-
est treatment for essential tremor may be ethanol, which tempo-
rarily ameliorates tremor; however, there are serious drawbacks to 
chronic use of ethanol for tremor management (3).
The etiology of essential tremor has not been elucidated (2). 
A major obstacle in the search for a mechanism is the lack of an 
adequate animal model for essential tremor. Current tremor mod-
els utilize drug- or lesion-induced tremors or arise from mutant 
strains. The only model sharing some features of essential tremor 
uses the γ-aminobutyric acidA (GABAA) receptor inverse agonist 
harmaline to induce a temporary tremor in animals (8) through its 
action at the inferior olive. However, animals develop rapid toler-
ance to harmaline, enhanced physiological tremor, and locomo-
tor deficits due to Purkinje cell degeneration and do not respond 
to propranolol (9–11). Although the harmaline model of tremor 
has made a valuable contribution to the understanding of human 
essential tremor, inconsistencies with essential tremor demon-
strate the need for additional models.
Several lines of evidence suggest that the GABAergic system is 
involved in the etiology of essential tremor because this major 
inhibitory system has a central role in motor control pathways. 
GABAA receptors are the primary inhibitory receptors in brain that 
regulate motor function (12–14). Tremor induction by harmaline 
has been attributed to inhibition of GABAA receptors resulting in 
enhanced electrical coupling of cerebellar afferents in the inferior 
olive (15). Patients with essential tremor have reduced cerebrospi-
nal fluid concentrations of GABA (16), and thalamic microinjec-
tion of the GABA agonist muscimol results in tremor arrest in 
patients (17). In addition, ethanol is particularly effective for treat-
ing essential tremor and has GABAergic effects that are believed to 
be related to its pharmacologic action (18–20).
Deletion of GABAA receptor α1 subunits results in the loss of 50% 
of all GABAA receptors in brain (21), including the motor pathways 
in brainstem, cerebellum, thalamus, and basal ganglia. Mice carry-
ing this deletion exhibit an essential-like tremor and motor incoor-
dination that mimics human essential tremor. To test the relevance 
of this model and to explore potential mechanisms underlying 
essential tremor, we examined the properties of the tremor and 
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responses to ethanol and drugs currently used to treat essential 
tremor. Purkinje cell morphology and function were examined in 
light of their involvement in the etiology of essential tremor. The 
results indicate that GABAA receptor α1–/– mice represent a useful 
genetic animal model of essential tremor that predicts new thera-
peutic targets and a potential etiology of the disease.
Results
Deletion of GABAA receptor α1 subunits produces essential-like tremor. 
GABAA receptor α1–/– mice develop normally but exhibit a tremor 
as they move freely about their cages. The tremor was observed in 
the first litters tested at the University of North Carolina at Chapel 
Hill (21) and has persisted through 9 generations of heterozygote 
breeding over more than 3 years. The tremor is most evident in the 
limbs, becomes significantly more pronounced upon tail suspension 
or movement, and is absent when the mouse is relaxed. The presence 
of postural and kinetic tremor is characteristic of essential tremor 
disorder. To determine the tremor frequency and amplitude (power) 
in GABAA receptor α1–/– mice, the animals were suspended by the 
tail from a force transducer and the displacement of the whole ani-
mal was measured over time. Physiologic tremor was observed in 
wild-type (α1+/+) and heterozygous (α1+/–) mice with mean frequen-
cies between 32.2 and 35.0 hertz (Hz) and maximal power ranging 
between 2.6 × 1011 and 6.00 × 1011 N (Figure 1, A and B). Homozygous 
(α1–/–) mice exhibited a pronounced pathologic tremor at a lower 
mean frequency of 19.3 ± 0.9 Hz and a greater mean maximal power 
of 24.3 × 1011 ± 4.2 × 1011 N and a physiologic tremor similar to that 
of α1+/+ and α1+/– mice (Figure 1C). In addition, motor coordination 
was determined by performance on the accelerating rotorod. Com-
pared with α1+/+ mice, α1–/– mice demonstrated significant impair-
ment in their ability to remain on 
the rotating rod (Table 1). Deficits 
in motor coordination of the fore-
arms and tandem gait are com-
monly observed in patients with 
essential tremor (4, 22, 23).
Essential tremor medications reduce 
tremor amplitude in α1–/– mice. 
Patients with essential tremor 
respond positively to a small num-
ber of drugs, including primidone, 
propranolol, and gabapentin (3). 
The efficacy of these drugs was 
investigated to determine whether 
α1–/– mice respond like patients 
with essential tremor. Primidone, 
gabapentin, and propranolol were 
effective in α1–/– mice, significant-
ly reducing tremor by 45–70% 
(Table 2). The effect of proprano-
lol is similar to that in essential 
tremor patients, where 50–60% 
reductions in tremor amplitude 
are observed (24).
Ethanol ameliorates tremor via non-
GABAergic mechanisms. Although 
rarely prescribed to patients with 
essential tremor, alcohol (ethanol) 
markedly reduces tremor ampli-
tude through action on a central 
component (20). Ethanol completely blocked the pathologic trem-
or in α1–/– mice in a dose-dependent manner (Figure 2A). Ethanol 
was remarkably potent with an apparent IC50 of 0.35 g/kg etha-
nol, a nonsedating dose in mice (24). Ethanol had no effect over-
all on the frequency or power of physiologic tremor in α1+/+ mice, 
although an activating effect was observed at the lowest dose.
Ethanol acts on several neurotransmitter systems that could con-
tribute to reduction of tremor, including inhibition of N-methyl- 
D-aspartate (NMDA) receptors (25), potentiation of GABAA receptor–
mediated neurotransmission (18), and enhancement of adenosin-
ergic transmission (26). The NMDA receptor antagonist MK-801 
significantly reduced the power of the pathologic tremor in a dose-
dependent manner, suggesting that ethanol may exert its effects by 
inhibiting the NMDA subtype of glutamate receptors (Figure 2B). 
MK-801 exhibited an IC50 of 0.024 mg/kg and a maximal effect of 
65–80% inhibition. The adenosine agonist 2-chloro-N6-cyclopen-
Figure 1
GABAA receptor α1–/– mice exhibit essential-like tremor. Normal physiologic tremor (wide range of low-
power frequencies, 25–40 Hz) was observed in α1+/+, α1+/–, and α1–/– mice. Knockout mice also exhib-
ited pathologic tremor (small range of high-power frequencies, 17–21 Hz) characteristic of essential 
tremor. Representative voltage tracings and Fourier transformation of tremor-induced displacement is 
shown for α1+/+ (A), α1+/– (B), and α1–/– (C) mice. (A) α1+/+ mice exhibit a tremor with a mean maximal 
power of 2.6 × 1011 ± 3.2 × 1011 N and a mean frequency of 32.1 ± 0.6 Hz (n = 16); (B) α1+/– mice, mean 
maximal power of 6.0 × 1011 ± 1.1 × 1011 N and mean frequency of 35.0 ± 1.9 Hz (n = 5); (C) α1–/– mice, 
mean maximal power of 24.3 × 1011 ± 4.2 × 1011 N and mean frequency of 19.3 ± 0.9 Hz (n = 13). Tremor 
is plotted as the voltage generated upon displacement of the transducer as a function of time (seconds). 
The power of individual frequencies that contribute to the overall tremor was determined by Fourier 
transformation of the voltage trace over time.
Table 1
GABAA receptor α1–/– mice exhibit motor incoordination on the 
rotorod
Genotype Latency to fall (seconds) Difference (%)
α1+/+ 54.9 ± 3.1 
α1–/– 32.0 ± 4.9A 41.7
Mice were tested for motor incoordination using 10 trials on an accel-
erating rotorod test (rod accelerates from 5 rpm to 45 rpm over 2 
minutes). Data represent mean time on rod ± SEM for the final 3 trials 
(n = 10 per genotype). AGABAA receptor α1–/– mice are significantly 
impaired (P < 0.001) as measured by time to fall off the rod compared 
with α1+/+ mice.
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tyladenosine (CCPA) reduced tremor severity by approximately 60% 
in α1–/– mice (Table 2), although significant motor incoordination 
was observed. Therefore, the contribution of the peripheral effect of 
CCPA on reduction of the tremor is currently unknown. Potentia-
tion of GABAergic neurotransmission by the benzodiazepine diaz-
epam and the neuroactive steroid allopregnanolone exacerbated the 
power of the pathologic tremor in α1–/– mice, whereas the GABAA 
receptor inverse agonist Ro15-4513 had no effect (Table 2). Because 
primidone, gabapentin, and ethanol block voltage-gated Ca2+ chan-
nels, the L-type Ca2+ channel antagonist nitrendipine was tested at 
a dose that blocks ethanol withdrawal seizures; however, it did not 
have a measurable effect on tremor amplitude (Table 2).
Cerebellar Purkinje cells of α1–/– mice lack responses to endogenous 
or exogenous GABA. A functional disturbance of the olivocerebel-
lar circuit is postulated to mediate human essential tremor. To 
understand the etiology of the tremor and motor incoordina-
tion in α1–/– mice, we focused on cerebellar Purkinje cells that 
integrate excitatory input from the inferior olive and cerebellar 
granule cells and inhibitory input from cerebellar interneurons 
to control the primary output of the cerebellar cortex, playing a 
central role in motor coordination. Because Purkinje cells pri-
marily express the α1 subunit–containing subtype (type 1) of 
GABAA receptors (27) and Purkinje cell degeneration produces 
tremor, we first determined whether deletion of GABAA receptor 
α1 subunits caused a loss of Purkinje cells. No difference in the 
number (46.0 ± 2.7 cells/mm3 in α1+/+ mice) or morphology of 
calbindin-stained Purkinje cells was observed between genotypes 
at 4, 8, or 16 months of age, demonstrating that the tremor is 
not caused by Purkinje cell degeneration (Figure 3A). Further-
more, the spontaneous firing rate of Purkinje cells in α1+/+ and 
α1–/– mice did not differ (Figure 3B).
Profound whole-cell electrophysiological changes were observed in Pur-
kinje cells of α1–/– mice. Spontaneous GABAergic inhibitory post-
synaptic potentials were absent in Purkinje cells recorded from 
dissociated neurons (Figure 3C). Similar results were found in cer-
ebellar slices (data not shown). In addition, GABA-gated currents 
in dissociated Purkinje cells were undetectable at concentrations 
up to 100 μM GABA in α1–/– mice compared with a concentration-
dependent response observed in α1+/+ mice (Figure 3, D and E).
Discussion
The principal finding of this study is that deletion of the GABAA 
receptor α1 subunit results in a mouse with a persistent postural 
and kinetic tremor, characteristic of human essential tremor dis-
ease. Tremor was observed in the first generation of GABAA recep-
tor α1–/– mice (21) and has persisted through more than 9 genera-
tions of mice. Our first report on these mice (28) failed to recognize 
the phenotype, probably owing to the focus on electrophysiological 
analysis rather than behavior. The tremor is easily observed in all 
3 laboratories that currently breed the mice. Current drug therapy 
for essential tremor was efficacious in reducing tremor in α1–/– 
mice. Furthermore, the tremor in α1–/– mice responded to ethanol, 
MK-801, and CCPA, suggesting that glutamatergic and adenosin-
ergic mechanisms are involved in the inhibitory effects of ethanol 
and are potential targets for novel pharmacotherapy. GABAA α1–/– 
mice exhibit a complete loss of both endogenous and exogenous 
GABA inhibition in cerebellar Purkinje cells. In addition, these 
mice exhibit the loss of 50% of all GABAA receptor binding sites 
throughout the brain, including brain regions in the major motor 
pathways from the brainstem to the thalamus and the basal gan-
glia (21). It is likely that loss of GABA inhibition in these motor 
pathways underlies tremor in α1–/– mice.
There are many similarities between tremor in GABAA receptor 
α1–/– mice and human essential tremor disease (Table 3). Deletion 
of the GABAA receptor α1 subunit produces a pathologic tremor 
with postural and kinetic components similar to essential tremor 
disorder. Furthermore, the tremor is genetic and persistent when 
compared with existing models that produce a chemical-induced 
tremor that is short-lived. Human physiologic and essential tremor 
occur at frequency ranges of 8–12 Hz and 4–8 Hz, respectively (29). 
The higher frequency of both physiologic and pathologic tremor 
in rodents is probably due to the smaller size of the animal. The 
appearance of a pathologic tremor at 19 Hz, relative to the physi-
ologic tremor frequency of 25–40 Hz in α1–/– mice, is indicative of 
essential tremor rather than enhanced physiologic tremor.
The efficacy of drugs used in the treatment of human essential 
tremor was observed in α1–/– mice, lending further support to 
the model. The ability of the first-line treatments, primidone and 
propranolol, to alleviate essential tremor in α1–/– mice supports 
Table 2
Pharmacological modulation of tremor amplitude in GABAA 
receptor α1–/– mice
Drug Dose (mg/kg) Percent of vehicle  n 
  response ± SEM
Primidone 50 56 ± 22A 10
Propranolol 10 31 ± 7A 12
Gabapentin 40 31 ± 11B 8
CCPA 1 39 ± 11A 8
Nitrendipine 50 159 ± 63 4
Diazepam 10 3,000 ± 737A 6
Allopregnanolone 16 540 ± 170A 6
Ro15-4513 10 112 ± 25 11
Pathologic tremor amplitude was determined in α1–/– mice (see Methods) 
following treatment with vehicle and then drug. Tremor amplitude fol-
lowing drug treatment is presented as percentage of vehicle response ± 
SEM. n indicates number of subjects tested per drug. The mean tremor 
amplitude in vehicle-treated mice was 5.5 × 1012 ± 0.8 × 1012. AP < 0.05 
and BP < 0.01 versus vehicle-treated control (paired Student’s t test).
Figure 2
Inhibition of essential-like tremor in GABAA receptor α1–/– mice by 
ethanol and MK-801. (A) Ethanol (0.25–2.5 g/kg) inhibited the essen-
tial-like tremor (approximately 19 Hz) in α1–/– mice in a dose-depen-
dent manner with an ED50 of 0.35 mg/kg reaching a maximal inhibi-
tion of 100% (n = 5–11 per genotype). Ethanol (0.25 g/kg) increased 
physiological tremor (approximately 32 Hz) in α1+/+ mice but lacked 
any effect at higher doses. (B) MK-801 (0.01–0.2 mg/kg) reduced the 
approximately 19 Hz tremor power in α1–/– mice with an ED50 of 0.024 
mg/kg reaching a maximal inhibition of 65–80% (n = 5–6). *P < 0.05; 
**P < 0.01; ***P < 0.001.
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common mechanisms with human essential tremor. Further-
more, successful novel application of drugs such as the anticon-
vulsant gabapentin in both α1–/– mice and patients demonstrates 
the necessity for animal models in which new and existing drugs 
can be screened for clinical utility (7). GABAA receptor α1–/– mice 
provide a useful animal model with which to investigate the 
pathophysiology of essential-like tremor and the mechanisms by 
which current and future therapies exert their effects.
Ethanol is effective in the suppression of essential tremor symp-
toms in humans and α1–/– mice. Ethanol was the most effective treat-
ment of tremor in α1–/– mice at doses that preclude the contribution 
of its sedative effects on tremor (30). Ethanol is believed to act cen-
trally in the alleviation of tremor and, in human studies, has been 
shown to involve a central component (20). Furthermore, positron 
emission tomography studies have shown that ethanol consumption 
increases cerebral blood flow in the inferior 
olivary nucleus, a central oscillator, which 
coincides with alleviation of tremor (31).
The mechanism responsible for etha-
nol’s effects on tremor appears to involve 
inhibition of excitatory glutamatergic 
transmission but not activation of inhibi-
tory GABAergic receptors. The efficacy of 
the glutamatergic antagonist MK-801 but 
not of GABAergic agonists diazepam and 
allopregnanolone suggest that the tremor 
may result from inactivation of inhibitory 
neurons. Although the lack of tremor inhi-
bition by diazepam in α1–/– mice is consis-
tent with low responsiveness in patients 
with essential tremor (20), the augmenta-
tion of tremor by diazepam was unexpect-
ed. Ethanol has several other targets in the 
brain that could account for its effects. 
Ethanol-sensitive adenosine receptors 
may be involved; however, studies with the 
adenosine agonist CCPA did not eliminate 
the possibility for peripheral effects of the 
drug, because significant motor incoordi-
nation was also observed in the mice.
Disruption of Purkinje cell function fol-
lowing deletion of GABAA receptor α1 sub-
units likely contributes, in part, to the eti-
ology of the tremor in α1–/– mice. The loss 
of GABAergic inhibition on Purkinje cells 
suggests that α1 subunit expression is criti-
cal for normal function of motor circuits 
and likely contributes to tremor and motor 
incoordination observed in α1–/– mice. 
Tremor induced by alcohol withdrawal is 
clinically similar to essential tremor and 
also results in decreased α1 subunit expres-
sion in rat cerebellum (32, 33). The lack of 
change in spontaneous activity of Purkinje 
cells is consistent with the lack of resting 
tremor and implies some adaptation to the 
loss of α1 subunits in these mice. Although 
compensatory changes in other GABAA 
receptor subunits have been observed in 
some brain regions of α1–/– mice (21), no 
GABAergic compensation in cerebellar Purkinje cells was found (data 
not shown). Because α1 subunits are normally expressed in other 
cells of this motor pathway, including the deep cerebellar nuclei and 
thalamus (but not the inferior olive), it is likely that communication 
among these regions is also disturbed by α1 subunit deletion and 
subsequent adaptations in receptor subunit expression. Although we 
have described altered GABA responses in the cerebellum, impair-
ment of GABAergic inhibition is likely throughout the motor path-
ways that could contribute to the observed tremor. Additional stud-
ies will be required to determine if loss of α1 subunits in any single 
brain area is sufficient to mimic the clinical manifestations of human 
essential tremor disease. Furthermore, a common target of the major 
drugs used to treat essential tremor (primidone and propranolol) has 
not been elucidated. Therefore, treatment of essential tremor may 
target several pathways in the brain.
Figure 3
GABAA receptor α1–/– mice exhibit normal Purkinje cell number and morphology but complete 
loss of both spontaneous mIPSCs and exogenous GABA inhibition of whole-cell voltage-clamp 
electrophysiological responses. (A) Calbindin staining of Purkinje cell number and morphology in 
cerebellum of 8-month-old α1+/+ and α1–/– mice. Magnification, ×400. (B) Similar spontaneously 
active Purkinje cells were found in both α1+/+ (22 of 29 penetrations) and α1–/– (28 of 36 penetra-
tions) mice. Mean rate for α1–/– mice (26.7 ± 3.8) did not differ from that of α1+/+ mice (32.4 ± 5.5). 
(C) Spontaneous mIPSCs recorded over a 30-second period from a Purkinje cell mechanically 
dissociated from an α1+/+ and α1–/– mouse. Spontaneous postsynaptic picrotoxin-sensitive cur-
rents with amplitude greater than 50 pA and fall-times greater than 4 ms were recorded from 10 
of 16 α1+/+ mice and 0 of 14 α1–/– mice. (D) Whole-cell voltage-clamp recordings were obtained 
from mechanically dissociated cerebellar Purkinje cells from α1+/+ and α1–/– mice. GABA was 
applied to the neurons by a U-tube. GABA (3, 30, and 100 μM) gated a concentration-depen-
dent inward current when applied to Purkinje cells from α1+/+ mice, but no current was gated in 
α1–/– Purkinje cells. (E) Mean GABA-gated currents from cerebellar Purkinje cells mechanically 
isolated from α1+/+ or α1–/– mice. There was a statistically reliable concentration-related increase 
in GABA response in the α1+/+ mice (*P < 0.001) but no effect of GABA in the α1–/– mice (P > 0.1) 
(n = 6–11 neurons per group).
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The similarities between human essential tremor and pathologic 
tremor in α1–/– mice suggest that expression of α1 subunits in the 
brains of patients with essential tremor may be abnormal. Further 
studies are needed to test this possibility. The GABAA receptor α1–/– 
mouse model of essential tremor provides a behavioral paradigm 
with predictive validity for testing novel potential treatments for 
this prevalent disorder.
Methods
Mutant mice. Production of GABAA receptor α1+/+, α1+/–, and α1–/– mice was 
previously described (28). Wild-type controls were homozygous for a floxed 
α1 allele that was functionally equivalent to the wild-type allele. GABAA 
receptor α1–/– mice were homozygous for a cre-mediated global deletion of 
exon 8 of the α1 gene. All mice were of a mixed C57BL/6J, 129Sv/SvJ, and 
FVB/N genetic background of F8+ generations and genotyped by Southern 
blot analysis. Mice were group-housed, provided ad libitum access to food 
and water, and maintained under a 12-hour light/12-hour dark schedule 
with lights on at 0700. All animal experiments were conducted in accor-
dance with the Guide for the Care and Use of Laboratory Animals by the 
NIH and were approved by the Institutional Animal Care and Use Commit-
tees at the University of North Carolina and the University of Memphis.
Drugs. Vehicles were saline for ethanol (AAEPER Alcohol), MK-801 
(Sigma-Aldrich), CCPA (Sigma-Aldrich), primidone (Sigma-Aldrich), pro-
pranolol (MP Biochemicals), nitrendipine (Axxora), and gabapentin (Sigma-
Aldrich); 20% 2-hydroxypropyl-β-cylcodextrin (Sigma-Aldrich)/saline for 
allopregnanolone (provided by R. Purdy, The Scripps Research Institute, 
La Jolla, California, USA); and 1% Tween-80 (MP Biochemicals)/saline for 
diazepam (Biomol) and Ro-154513 (Sigma-Aldrich).
Tremor measurement. Tremor was quantified by determination of ampli-
tude and frequency using a tremor monitor built in the Bowles Center 
for Alcohol Studies at the University of North Carolina. Tremor was 
measured in mice suspended by the tail for 22 seconds so that the ani-
mals held a posture against gravity and the tremor was easily observed 
and measured. The mice exhibited no signs of stress (defecation, vocal-
ization, biting, or jumping) during the measurement as the mice were 
accustomed to handling by tail suspension in the laboratory. Each mouse 
was suspended by its tail from a cord attached to the center of a stereo 
speaker (Archer 3” 8Ωmax2W). Tremor resulted in vibration of the speak-
er surface and the resulting signal was amplified before passing through 
an analog-to-digital converter that assigned voltage equivalents to the 
vibrations transmitted to the speaker. These voltage measurements were 
analyzed via a Pascal program developed in house. Voltage recordings 
were made over a 22-second period at a rate of 454 recordings per second. 
The data obtained from the program was analyzed using MatLab (Math-
works) by Fourier transformation to determine the peak amplitude and 
frequency of the tremor for each animal.
For all drugs tested (except ethanol), each animal served as its own control 
in which a baseline measurement of tremor was obtained following admin-
istration of vehicle. Dose-response curves for MK-801 were generated by 
administration of each dose to a group of animals in a χ2 design. Animals 
were tested at 3-day intervals to allow clearance of drug. Each animal was used 
to test 1 drug. For ethanol, every dose was tested in a separate group of mice. 
Drugs and vehicles were administered intraperitoneally in a 10 ml/kg injec-
tion volume 1 hour (45 minutes for CCPA) before measurement of tremor.
Motor coordination. Mice were tested on an accelerating rotorod (Columbus 
Instruments) with a rod diameter of 3 inches that accelerated from 5 to 45 
rpm over 2 minutes. Mice were placed on the rotating rod (5 rpm) and each 
trial lasted until the mouse fell off the rod. Each mouse was given 10 trials on 
the rotorod. For each trial, the length of time the mouse stayed on the rotorod 
was recorded. The mean was calculated from the last 3 trials for each mouse.
Immunohistochemical methods. Mice were sacrificed at 4, 8, and 16 months 
of age, perfused, and processed as previously described (34), with cerebella 
serially sectioned (10 μm) in the sagittal plane. Purkinje cells were labeled 
using an anti-calbindin rabbit polyclonal antibody (Chemicon). Calbindin-
positive cells were profile-counted throughout the entire cerebellum. The 
area of each cerebellum tissue section was determined using the Bioquant 
system and data expressed as the number of Purkinje cells per mm2.
Electrophysiological recording. Action potentials from cerebellar Purkinje 
cells in a slice preparation were recorded extracellularly using an Axon 
Instruments Axopatch-200A in track mode. Cerebellar slices (250 μm) from 
20- to 40-day-old mice were cut in cold artificial cerebrospinal fluid (aCSF) 
(124 mM NaCl, 3.25 mM KCl, 1.25 mM KH2PO4, 1 mM CaCl2, 20 mM 
NaHCO3, 2 mM MgSO4, and 10 mM glucose). Slices were maintained with 
continuous 95% O2 and 5% CO2 for at least 1 hour before use. Slices were 
transferred to a recording chamber under an upright microscope where they 
were continuously bathed in aCSF. Purkinje cells were identified using infra-
red illumination and differential interference contrast optics. Recording 
pipettes were fabricated from N51A capillary glass (Drummond Scientific) 
Table 3
GABAA receptor α1–/– mouse model reflects aspects of human essential tremor
Characteristic Human essential tremor GABAA receptor α1–/– mice
Tremor type Persistent, visible, bilateral, postural, kinetic Persistent, visible, bilateral, postural, kinetic
Tremor locationA Upper limbs and, less frequently, lower limbs, affecting  Fore and hind limbs equally effected, causing  
  ability to clothe and feed oneself  impairment of balance on rotating rod
Tremor frequencyB 4–8 Hz compared with 8–12 Hz physiological tremor 15–19 Hz compared with 25–40 Hz  
   physiological tremor
Response to drug treatment +: primidone, propranolol, ethanol, gabapentin +: primidone, propranolol, ethanol, gabapentin,  
   MK-801, CCPA; –: diazepam, allopregnanolone,  
   Ro15-4513, nitrendipine
Etiology Unknown  Disruption of inhibitory GABAergic signaling throughout  
   brain, complete loss of GABA inhibition in cerebellar  
   Purkinje cells
Response to thalamotomy  + ? 
and deep brain stimulation
AUpper limb motor incoordination in humans is comparable to incoordination of mice on rotating rod. BDifference in tremor frequency between rodent and 
human is species-dependent, but both exhibit pathologic tremor of lower frequency than physiologic tremor.
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 115   Number 3   March 2005 779
and filled with HEPES-buffered aCSF (described below). The electrode was 
apposed to a Purkinje cell, and if no spontaneous activity was observed, 
it was lowered through the Purkinje layer for 100 μm or until an active 
neuron was found. Probability of finding a neuron during the 100-μm 
penetration and firing rate of each neuron were recorded.
Spontaneous GABA-gated miniature inhibitory postsynaptic currents 
(mIPSCs) and currents generated by exogenously applied GABA were 
measured in the slice preparation and in mechanically dissociated cer-
ebellar Purkinje cells using standard whole-cell voltage-clamp recording. 
For dissociation, slices (as described above) were transferred into standard 
HEPES-buffered recording medium (145 mM NaCl, 5 mM KCl, 10 mM 
HEPES, 2 mM CaCl2, and 10 mM glucose, pH 7.4; 340 milliosmoles per 
liter) with room air, and a vibrating probe (60 Hz; 0.5–1 mm amplitude) 
was touched to the surface of the slice for 30–60 seconds. The slice was 
removed and the dissociated neurons allowed to settle onto the floor of 
the recording chamber. This procedure dissociates Purkinje cells with 
intact presynaptic terminals, allowing recording of mIPSCs.
Voltage-clamp (–60 mV) recording in the whole-cell configuration 
was accomplished using an Axopatch-1D amplifier. Recording pipettes 
were fabricated from N51A capillary glass (Drummond Scientific). The 
internal solution used for measuring mIPSCs and ion currents induced 
by GABA included 150 mM KCl, 3.1 mM MgCl2, 15 mM HEPES, 2 mM 
K-ATP, 5 mM EGTA, 15 mM phosphocreatine, 500 nM tetrodotoxin, 
and 50 U/ml creatine phosphokinase. This solution was adjusted to pH 
7.4 with KOH and osmolality of 310 milliosmoles per liter with sucrose. 
A U-tube was used to apply varying concentrations of GABA to neurons. 
Counts of action potentials and mIPSCs were detected off-line using 
Mini Analysis software (Synaptosoft).
Statistical analysis. Data were analyzed using Prism (GraphPad). All data 
were presented as mean (or mean percent control) ± SEM and subjected to 
Student’s t test or ANOVA with an appropriate post hoc test. Dose respons-
es were analyzed by nonlinear regression. The IC50 was defined as the drug 
dose that inhibited 50% of the pathologic tremor and maximal effect as the 
best-fit bottom value estimated by nonlinear regression.
Acknowledgments
This research was supported by NIH grants AA11605 (to A.L. Mor-
row and G.R. Breese), AA09013 (to A.L. Morrow), MH61971 (to 
D.B. Matthews and K. Hamre), AA10422, and GM52035 (to G.E. 
Homanics). We thank Jean-Marc Fritschy and Kirk Wilhelmson for 
discussion of the manuscript.
Received for publication October 14, 2004, and accepted in revised 
form December 21, 2004.
Address correspondence to: A. Leslie Morrow, University of North 
Carolina School of Medicine, CB No. 7178, 3027 Thurston-Bowles 
Building, University of North Carolina at Chapel Hill, Chapel Hill, 
North Carolina 27599-7178, USA. Phone: (919) 966-7682; Fax: 
(919) 966-9099; E-mail: morrow@med.unc.edu.
Jason E. Kralic’s present address is: Institute of Pharmacology and 
Toxicology, University of Zurich, Zurich, Switzerland.
Jason E. Kralic, Hugh E. Criswell, Jessica L. Osterman, and A. Leslie 
Morrow contributed equally to this work.
 1. Louis, E.D., Ottman, R., and Hauser, W.A. 1998. How 
common is the most common adult movement dis-
order? Estimates of the prevalence of essential tremor 
throughout the world. Mov. Disord. 13:5–10.
 2. Chen, J.J., and Swope, D.M. 2003. Essential trem-
or: diagnosis and treatment Pharmacotherapy. 
23:1105–1122.
 3. Pahwa, R., and Lyons, K.E. 2003. Essential tremor: 
Differential diagnosis and current therapy. Am. J. 
Med. 115:134–142.
 4. Hubble, J.P., Busenbark, K.L., Pahwa, R., Lyons, K., 
and Koller, W.C. 1997. Clinical expression of essen-
tial tremor: effects of gender and age. Mov. Disord. 
12:969–972.
 5. Gorman, W.P., Cooper, R., Pocock, P., and Camp-
bell, M.J. 1986. A comparison of primidone, pro-
pranolol, and placebo in essential tremor, using 
quantitative analysis. J. Neurol. Neurosurg. Psychiatr. 
49:64–68.
 6. O’Brien, M.D., Upton, A.R., and Toseland, P.A. 
1981. Benign familial tremor treated with primi-
done. Br. Med. J. (Clin. Res. Ed.). 282:178–180.
 7. Gironell, A., et al. 1999. A randomized placebo-
controlled comparative trial of gabapentin and 
propranolol in essential tremor. Arch. Neurol. 
56:475–480.
 8. Wilms, H., Sievers, J., and Deuschl, G. 1999. Animal 
models of tremor. Mov. Disord. 14:557–571.
 9. Iwata, S., Nomoto, M., and Fukuda, T. 1993. Effects 
of β-adrenergic blockers on drug-induced tremors. 
Pharmacol. Biochem. Behav. 44:611–613.
 10. O’Hearn, E., and Molliver, M.E. 1993. Degenera-
tion of Purkinje cells in parasagittal zones of the 
cerebellar vermis after treatment with ibogaine or 
harmaline. Neuroscience. 55:303–310.
 11. Wang, G., and Fowler, S.C. 2001. Concurrent quan-
tification of tremor and depression of locomotor 
activity induced in rats by harmaline and physo-
stigmine. Psychopharmacology. 158:273–280.
 12. Barnard, E.A., et al. 1998. International Union of 
Pharmacology. XV. Subtypes of gamma-aminobu-
tyric acidA receptors: classification on the basis of 
subunit structure and receptor function. Pharma-
col. Rev. 50:291–313.
 13. Rudolph, U., et al. 1999. Benzodiazepine actions 
mediated by specific gamma-aminobutyric acidA 
receptor subtypes. Nature. 401:796–800.
 14. Sieghart, W. 2000. Unraveling the function of 
GABAA receptor subtypes. Trends Pharmacol. Sci. 
21:411–413.
 15. Stratton, S.E., and Lorden, J.F. 1991. Effect of har-
maline on cells of the inferior olive in the absence 
of tremor: differential response of genetically dys-
tonic and harmaline-tolerant rats. Neuroscience. 
41:543–549.
 16. Mally, J., Baranyi, M., and Vizi, E.S. 1996. Change 
in the concentrations of amino acids in CSF and 
serum of patients with essential tremor. J. Neural. 
Transm. Gen. Sect. 103:555–560.
 17. Pahapill, P.A., et al. 1999. Tremor arrest with 
thalamic microinjections of muscimol in patients 
with essential tremor. Ann. Neurol. 46:249–252.
 18. Suzdak, P.D., Schwartz, R.D., Skolnick, P., and 
Paul, S.M. 1986. Ethanol stimulates γ-aminobu-
tyric acid receptor-mediated chloride transport in 
rat brain synaptoneurosomes. Proc. Natl. Acad. Sci. 
U. S. A. 83:4071–4075.
 19. Mihic, S.J., et al. 1997. Sites of alcohol and volatile 
anaesthetic action on GABAA and glycine recep-
tors. Nature. 389:385–389.
 20. Zeuner, K.E., et al. 2003. Effect of ethanol on the 
central oscillator in essential tremor. Mov. Disord. 
18:1280–1285.
 21. Kralic, J.E., Korpi, E.R., O’Buckley, T.K., Homanics, 
G.E., and Morrow, A.L. 2002. Molecular and phar-
macological characterization of GABAA receptor 
α1 subunit knockout mice. J. Pharmacol. Exp. Ther. 
302:1037–1045.
 22. Lou, J.S., and Jankovic, J. 1991. Essential tremor: 
clinical correlates in 350 patients. Neurology. 
41:234–238.
 23. Elble, R.J. 2002. Essential tremor is a monosymp-
tomatic disorder. Mov. Disord. 17:633–637.
 24. Koller, W.C., and Vetere-Overfield, B. 1989. Acute 
and chronic effects of propranolol and primidone 
in essential tremor. Neurology. 39:1587–1588.
 25. Lovinger, D.M., White, G., and Weight, F.F. 1989. 
Ethanol inhibits NMDA-activated ion currents in 
hippocampal neurons. Science. 243:1721–1724.
 26. Gordon, A.S., Collier, K., and Diamond, I. 1986. 
Ethanol regulation of adenosine receptor-stimu-
lated cAMP levels in a clonal neural cell line: an in 
vitro model of cellular tolerance to ethanol. Proc. 
Natl. Acad. Sci. U. S. A. 83:2105–2108.
 27. Laurie, D.J., Seeburg, P.H., and Wisden, W. 1992. 
The distribution of 13 GABAA receptor subunit 
mRNAs in the rat brain. II. Olfactory bulb and cer-
ebellum. J. Neurosci. 12:1063–1076.
 28. Vicini, S., et al. 2001. GABAA receptor α1 sub-
unit deletion prevents developmental changes of 
inhibitory synaptic currents in cerebellar neurons. 
J. Neurosci. 21:3009–3016.
 29. Elble, R.J. 1986. Physiologic and essential tremor. 
Neurology. 36:225–231.
 30. Kralic, J.E., et al. 2003. Deletion of GABAA receptor 
alpha1 subunit-containing receptors alters respons-
es to ethanol and other anesthetics. J. Pharmacol. Exp. 
Ther. 305:600–607.
 31. Boecker, H., et al. 1996. The effect of ethanol on alco-
hol-responsive essential tremor: a positron emission 
tomography study. Ann. Neurol. 39:650–658.
 32. Morrow, A.L., Herbert, J.S., and Montpied, P. 1992. 
Differential effects of chronic ethanol administration 
on GABAA receptor α1 and α6 subunit mRNA levels 
in rat cerebellum. Mol. Cell. Neurosci. 3:251–258.
 33. Mhatre, M.C., Pena, G., Sieghart, W., and Ticku, 
M.K. 1993. Antibodies specific for GABAA receptor 
α subunits reveal that chronic ethanol treatment 
down-regulates α-subunit expression in rat brain 
regions. J. Neurochem. 61:1620–1625.
 34. Crews, F.T., Nixon, K., and Wilkie, M.E. 2004. Exer-
cise reverses ethanol inhibition of neural stem cell 
proliferation. Alcohol. 33:63–71.
